Medical/Pharmaceuticals
Antengene to Host its First R&D Days on November 16 and November 18, 2021
* Virtual Event (in English) on November 16 * On Site Event with Live Webcast (in Mandarin) on Nov 18 SHANGHAI and HONG KONG, Oct. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, deve...
2021-10-25 20:00
4398
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management
SHANGHAI, Oct. 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Chugai Phar...
2021-10-25 19:00
2741
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer
HOUSTON and SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced it has entered into a clinical trial collaboration agreem...
2021-10-25 17:00
2060
Farrer Park Hospital Offers Transcatheter Aortic Valve Implantation (TAVI)
SINGAPORE, Oct. 25 , 2021 /PRNewswire/ -- Farrer Park Hospital ("FPH") offers TAVI as an alternative treatment option for those suffering from aortic valve stenosis who are elderly or for younger patients who are not suitable for open-heart surgery. In aortic valve stenosis, the aortic valve sit...
2021-10-25 13:09
2997
A Singapore-based HealthTech Startup Redefines Chronic Disease Care with Promising Clinic Acquisition
SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- A HealthTech start-up, HeartVoice announced its acquisition of Integrated Wellness Clinic in Novena Specialist Center. The clinic has been offering Health Screening services for corporate clients since 2015, pioneering this field,having served over 600 cor...
2021-10-25 10:30
3468
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization's most-recent co...
2021-10-25 09:13
3727
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer
SHANGHAI, Oct. 23, 2021 /PRNewswire/ -- Polaris Biology, a leading innovator in
single-cell technologies, announced today the largest product launch in company
history with the introduction of the Starion™ Mass Cytometry System.
2021-10-23 15:05
3608
I-Mab Expands U.S. Footprint with New R&D Site in San Diego
- I-Mab will strengthen its global R&D presence, with a new world-class R&D and operational site, located in the heart of the rapidly growingSan Diego biotech hub - The new site will complement I-Mab's Global Clinical Development site in Gaithersburg, Maryland to form an integrated I-Mab US R&...
2021-10-22 20:00
2451
Ping An Good Doctor Unveils Strategic 2.0 Continuum
SHANGHAI, Oct. 22, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 01833.HK), the leading online medical and healthcare service platform in China, presented its business achievements and unveiled its Strategic 2.0 Continuum at an investor...
2021-10-22 17:08
3226
2021 Bio-enzyme Application Explorer Summit held in Chengdu
The event focuses on innovation and development of biochemical pharmaceuticals CHENGDU, China, Oct. 22, 2021 /PRNewswire/ -- The biochemical pharmaceutical industry is facing unprecedented opportunities and challenges with the changing economic and policy environment inChina and abroad. On Octobe...
2021-10-22 14:23
1977
Akeso is rapidly advancing the clinical study of the PD-1/CTLA-4 bispecific antibody Cadonilimab combined with TIGIT monoclonal antibody for the teratment of solid tumors
HONG KONG, Oct. 21, 2021 /PRNewswire/ -- Akeso, one of leading Chinese pharmaceutical innovation company announces that the first patient was dosed in a phase I clinical trial of the Company's independently developed TIGIT monoclonal antibody (AK127) in combination with the Company's global firs...
2021-10-22 09:50
2027
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore
SINGAPORE, Oct. 21, 2021 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner withIncyte Biosciences International Sàrl,the Swiss-based affiliate of Incyte (NASDAQ:INCY), to launch and distribute two new medicines for its haematology and onc...
2021-10-22 09:00
2419
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 295 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 284 media titles]
2026-10-15 10:00SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 282 media titles]
2026-10-15 12:59
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 273 media titles]
2026-10-21 15:00
Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
29353
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
19129